Patient centricity

ERT, Science 37 forge virtual trial data partnership

27-Aug-2020 By Jenni Spinner

The companies will work together on solutions designed to enable sponsors to improve imaging, respiratory and cardiac safety data on decentralized trials.

SubjectWell eyes diversity in COVID-19 vaccine trials

27-Aug-2020 By Jenni Spinner

The clinical trials marketplace company reportedly is connecting sites with 10,000 patients a month, with 40% of them from non-white groups.

Thread Research lands $50m infusion for decentralized trial tech

25-Aug-2020 By Jenni Spinner

The clinical research tech provider has received a capital commitment from healthcare industry investors to advance its decentralized trial solutions.

Veeva report highlights study start-up challenges

25-Aug-2020 By Jenni Spinner

The company has released a report revealing how clinical trial professionals are handling start-up, before and after COVID-19 first impacted the industry.

Study looks at COVID-era mobile health applications

24-Aug-2020 By Jenni Spinner

Led by the Spaulding Rehabilitation Hospital, a study by a 60-person task force shows ways mobile health tech can help mitigate the pandemic’s effects.

Centogene database offers rare-disease insights

24-Aug-2020 By Jenni Spinner

The newly expanded CentoMD 5.8 mutation database includes clinical, epidemiologic and phenotypic data from more than 430,000 analyzed cases.

Inato: insightful data can boost clinical trial diversity

20-Aug-2020 By Jenni Spinner

A leader from the clinical research technology firm talks about the importance of a diverse patient population and ways to hit the target.

Duchenne foundation funds research leading to first-in-human clinical study

19-Aug-2020 By Jenni Spinner

The research taking place at Nationwide Children’s Hospital is seeking a treatment for a rare Duchenne muscular dystrophy mutation.

Cerba Research: collaboration boosts rare-disease discoveries

19-Aug-2020 By Jenni Spinner

A leader from the clinical laboratory and diagnostic solution provider discusses how its research is fueled by partnerships and patient-centricity.

Healx collaborates on Angelman syndrome therapies

19-Aug-2020 By Jenni Spinner

The AI-centric drug discovery technology firm is working with a foundation to discover potential treatments for the rare neurogenetic disorder.

Drug discovery platform aims to accelerate rare-disease therapies

19-Aug-2020 By Jenni Spinner

An online patient community specializing in rare diseases has launched Xperiome, a knowledge platform aimed at speeding development of treatments.

Biorasi: precision medicine trials call for specialized approach

19-Aug-2020 By Jenni Spinner

A leader from the speed-focused CRO talks about the specialized needs of precision medicine trials, and how sites and sponsors can succeed on such studies.

Notable, Washington University join on oncology study

19-Aug-2020 By Jenni Spinner

The precision study at the center of the partnership is geared toward identifying novel synergies across a broad variety of anticancer therapies.

Illingworth: mobile nursing can reduce trial patient burden

18-Aug-2020 By Jenni Spinner

A leader from home-based clinical services firm Illingworth Research Group talks about the evolution of mobile nursing and how it can keep trials going.

BBK Worldwide on navigating patient travel in COVID-19 era

18-Aug-2020 By Jenni Spinner

A leader from the clinical trial patient engagement specialist discusses how clinical trial teams can tackle tricky travel issues in the face of the pandemic.